- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02600364
Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device
Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Title: Diversion-p64. Device: p64 Flow Modulation Device. Study design: Prospective, multicenter, single arm Post Market Clinical Follow-Up Study.
Purpose: To assess safety and effectiveness of p64. Study duration: 48 months. Sample Size: 400 patients. Number of sites: > 20. Follow-up intervals: Two independent follow-ups (after 3-6 and 7-12 months) according to site specific standard.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Buenos Aires, Argentina, 1642
- Clínica La Sagrada Familia
-
-
-
-
-
Genk, Belgien, 3600
- Ziekenhuis Oost-Limburg
-
-
-
-
-
Sofia, Bulgarien, 1431
- St. Ivan Rilski Hospital
-
-
-
-
-
Bordeaux, Frankrike, 33000
- Groupe Hospitalier Pellegrin
-
Bron, Frankrike, 69500
- Hôpital Pierre Wertheimer
-
Le Kremlin-Bicêtre Cedex, Frankrike, 94275
- Hôpital Bicêtre
-
Montpellier, Frankrike, 34295
- Hôpital Gui de Chauliac (CHU Montpellier)
-
Paris, Frankrike
- Hôpital Pitié Salpêtrière
-
Reims, Frankrike
- CHRU Hôpital Maison-Blanche
-
Tours cedex 9, Frankrike, 37044
- Hôpital Bretonneau (CHRU de Tours)
-
-
-
-
-
Bologna, Italien
- Ospedale Bellaria Carlo Alberto Pizzardi
-
Rozzano, Italien, 20089
- IRCCS Istituto Clinico Humanitas
-
-
-
-
-
Grudziądz, Polen, 86-300
- Regionalny Szpital Specjalistyczny
-
Wrocław, Polen, 50-556
- Uniwersytecki Szpital Kliniczny we Wroclawiu
-
-
-
-
-
Bucharest, Rumänien, 010718
- Life Memorial Hospital
-
-
-
-
-
Moscow, Ryska Federationen
- NSI Burdenko, Moscow
-
Saint Petersburg, Ryska Federationen
- Federal Almazov North-West Medical Research Centre
-
-
-
-
-
Edinburgh, Storbritannien, EH4 2XU
- Western General Hospital
-
Leeds, Storbritannien, LS1 3EX
- Leeds Teaching Hospitals NHS Trust
-
London, Storbritannien, SW17 0QT
- St George's Hospital
-
-
-
-
-
Augsburg, Tyskland, 86156
- Klinikum Augsburg
-
Bremen, Tyskland, 28205
- Klinikum Bremen-Mitte
-
Erfurt, Tyskland
- Helios Klinikum Erfurt
-
Recklinghausen, Tyskland, 45657
- Knappschaftskrankenhaus Recklinghausen
-
Regensburg, Tyskland, 93053
- Universitätsklinikum Regensburg
-
Stuttgart, Tyskland, 70174
- Klinikum Stuttgart Katharinenhospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria
- Age ≥ 18
- Patient harbours either one saccular or one dissecting or one blisterlike or one fusiform intracerebral aneurysm or one intracerebral segmental disease, in the anterior circulation for which the indication for p64 treatment is given
- Patient or legal representative provides written informed consent verifying that he/she consents to the use of his/her data (according to the data protection laws)
Exclusion Criteria
- Aneurysms of the posterior circulation
- Imaging evidence of bifurcation aneurysms
- Imaging evidence of dissections
- Imaging evidence of fistulae
- Imaging evidence of arteriovenous malformations
- Patient is harbouring another aneurysm that has to be treated within six months after first procedure
- Known allergy to study medication, e.g. ASA, Clopidogrel, Heparin or contrast media
- Confirmation of positive pregnancy test according to site specific standard of care (e.g. test, verbal communication)
- Current involvement in another study or trial
- Parent vessel treated with other Flow Diverters than p64 during intervention and re-treatment
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in the rate of complete occlusion
Tidsram: immediately after treatment, an expected average of 1 hour; to 12 months
|
Rate of complete aneurysm occlusion is assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 7-12 months).
The change is assesed.
|
immediately after treatment, an expected average of 1 hour; to 12 months
|
Change of frequency of major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm
Tidsram: immediately after treatment, an expected average of 1 hour; to 12 months
|
Frequency of major stroke (ischemic or hemorrhagic) or neurological death is assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 7-12 months).
The change is assesed.
|
immediately after treatment, an expected average of 1 hour; to 12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Intra-procedural technical complications
Tidsram: during treatment, an expected average of 1 hour
|
p64 placed in the desired location Correct opening of p64 (markers fully deployed) at the end of the procedure Ability to detach p64 at the end of the procedure
|
during treatment, an expected average of 1 hour
|
Change of Angiographic results
Tidsram: immediately after treatment, an expected average of 1 hour; to 12 months
|
Change in both Rate of re-growth (related rate of re-treatment) and Rate of recanalization (related rate of re-treatment) are assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 7-12 months).
|
immediately after treatment, an expected average of 1 hour; to 12 months
|
Intra-procedural vascular complications
Tidsram: during treatment, an expected average of 1 hour
|
Vessel perforation (e.g. with distal wire tip of p64, microcatheter) Target aneurysm perforation (e.g. with distal wire tip of p64, microcatheter) Thromboembolism Dissection of any access vessel Side branch occlusion
|
during treatment, an expected average of 1 hour
|
Post-procedural Complications
Tidsram: 3-6 and 7-12 months
|
Parenchymal hemorrhage detected during the follow-up period Subarachnoid hemorrhage detected during the follow-up period Ischemic stroke detected on follow-up imaging Rupture of the target aneurysm detected during the follow-up period Rate of in-stent-stenosis detected during the follow-up period
|
3-6 and 7-12 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Alain Bonafé, Prof. Dr., Hôpital Gui de Chauliac (CHU de Montpellier), Montpellier, France
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- DP64/BO1507
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Intrakraniell aneurysm
-
Nova Scotia Health AuthorityDalhousie UniversityAvslutadDissekera aneurysm i Thoracic AortaKanada
-
Microvention-Terumo, Inc.Semmes-Murphey FoundationRekrytering
-
Cook Group IncorporatedAvslutadAorto-iliaca aneurysm | Iliac aneurysmFörenta staterna
-
Galaxy Therapeutics INCAvslutadAneurysm | Aneurysm, sprucken | Aneurysm SaccularColombia
-
Cook Research IncorporatedAvslutadIliac aneurysm | Aortoiliaka aneurysmFörenta staterna
-
Cook Research IncorporatedInte längre tillgängligIliac aneurysm | Aortoiliaka aneurysmFörenta staterna
-
Lifetech Scientific (Shenzhen) Co., Ltd.OkändIliac aneurysm | Aortoiliaka aneurysmKina
-
General Hospital of Beijing PLA Military RegionAvslutadAneurysm dissekering
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloOkändCerebral aneurysm | Hjärnaneurysm | Aneurysm, mellersta cerebrala artären | Aneurysm, främre kommunicerande artär | Aneurysm, posterior kommunicerande artär | Aneurysm, halspulsådernBrasilien
-
Assistance Publique - Hôpitaux de ParisAvslutad